U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07216885) titled 'Solv Multi-Pass Hemodialysis System In-Center Clinical Study' on Oct. 06.
Brief Summary: Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
End Stage Renal Disease...